Universal Scientific Industrial (Shanghai) Co., Ltd. (SHA:601231)
21.82
+0.78 (3.71%)
Oct 23, 2026, 3:00 PM CST
SHA:601231 Revenue
Universal Scientific Industrial (Shanghai) had revenue of 13.99B CNY in the quarter ending June 30, 2026, with 3.11% growth. This brings the company's total for the last twelve months to 59.32B, down -1.98% year-over-year. In the year 2025, Universal Scientific Industrial (Shanghai) had annual revenue of 59.20B, down -2.46%. That makes Universal Scientific Industrial (Shanghai) the 1,638th largest company in the world by revenue and 168th in China.
Revenue (ttm)
59.32B
Revenue Growth
-1.98%
P/S Ratio
0.87
Revenue / Employee
2.73M
Employees
21,726
Market Cap
51.83B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:601231 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 59.20B | -1.50B | -2.46% |
| Dec 31, 2024 | 60.69B | -101.26M | -0.17% |
| Dec 31, 2023 | 60.79B | -7.72B | -11.27% |
| Dec 31, 2022 | 68.52B | 13.22B | 23.90% |
| Dec 31, 2021 | 55.30B | 7.60B | 15.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsUniversal Scientific Industrial (Shanghai) News
- 1 month ago - Universal Scientific Industrial (Shanghai) Quarterly report: Q2 2026 - Filings
- 5 months ago - Universal Scientific Industrial (Shanghai) Quarterly report: Q1 2026 - Filings
- 6 months ago - Universal Scientific Industrial (Shanghai) Annual report: Q4 2025 - Filings
- 11 months ago - Universal Scientific Industrial (Shanghai) Quarterly report: Q3 2025 - Filings